These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9399033)

  • 1. Hypertension in polycystic kidney disease type 1 and 2 and its effect on the age of onset of end-stage renal disease.
    Torra R; Badenas C; Pérez L; Estivill X; Darnell A
    Contrib Nephrol; 1997; 122():28-30. PubMed ID: 9399033
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dominant polycystic renal disease. Study of 105 cases].
    Kheder A; Ben Hamida F; el Younsi F; Abderrahim E; Safar M; Ben Ayed H; Ben Maiz H
    Rev Med Interne; 1992; 13(5):345-8. PubMed ID: 1344829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
    Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
    Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticipation of end-stage renal disease in autosomal dominant polycystic kidney disease.
    Gonzalo A; Gallego A; San Millan JL; Ortuño J
    Nephrol Dial Transplant; 1996; 11 Suppl 6():21-3. PubMed ID: 9044323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
    Cerasola G; Li Vecchi M; Mulé G; Cottone S; Mangano MT; Andronico G; Contomo A; Parrino IA; Renda F; Pavone G; Scialabba A
    Contrib Nephrol; 1997; 122():22-7. PubMed ID: 9399032
    [No Abstract]   [Full Text] [Related]  

  • 6. Genesis and significance of hypertension in autosomal dominant polycystic kidney disease.
    Zeier M; Ritz E; Geberth S; Gonzalo A
    Nephron; 1994; 68(2):155-8. PubMed ID: 7830851
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
    Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
    Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
    Lee KB; Kim UK
    Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations.
    Demetriou K; Tziakouri C; Anninou K; Eleftheriou A; Koptides M; Nicolaou A; Deltas CC; Pierides A
    Nephrol Dial Transplant; 2000 Feb; 15(2):205-11. PubMed ID: 10648666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case from practice (278). Familial polycystic kidney disease, adult type: increasing kidney insufficiency. Renal hypertension. Renal anemia].
    Fuhrimann P
    Schweiz Rundsch Med Prax; 1993 Sep; 82(39):1081-2. PubMed ID: 8210874
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical management of autosomal dominant polycystic kidney disease.
    Bennett WM; Elzinga LW
    Kidney Int Suppl; 1993 Jul; 42():S74-9. PubMed ID: 8361135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hypertension according to phenotype and gender in autosomal-dominant polycystic kidney disease.
    Boulahrouz R; Mazeau P; Charasse C; Catroux B; Le Cacheux P; Ang KS; Simon P
    Contrib Nephrol; 1997; 122():17-21. PubMed ID: 9399031
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentration of endothelin and arterial pressure in patients with ADPKD.
    Giusti R; Neri M; Angelini D; Carlini A; Fiorini I; Bigongiari P; Antonelli A
    Contrib Nephrol; 1995; 115():118-21. PubMed ID: 8585897
    [No Abstract]   [Full Text] [Related]  

  • 14. Autosomal dominant polycystic kidney disease.
    Torres VE; Harris PC; Pirson Y
    Lancet; 2007 Apr; 369(9569):1287-1301. PubMed ID: 17434405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen?
    Perrone RD; Miskulin DC
    Am J Kidney Dis; 2005 Sep; 46(3):557-9. PubMed ID: 16129219
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal manifestation of Autosomal Dominant Polycystic Kidney Disease].
    Galliani M; Chicca S; Vitaliano E; Di Lullo L; Giannakakis K; Paone A
    G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
    Torra R; Badenas C; Darnell A; Nicolau C; Volpini V; Revert L; Estivill X
    J Am Soc Nephrol; 1996 Oct; 7(10):2142-51. PubMed ID: 8915974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical view of autosomal dominant polycystic kidney disease].
    Rózański J; Myślak M; Domański L; Ciechanowski K; Szmatłoch E
    Pol Arch Med Wewn; 2000 Aug; 104(2):525-31. PubMed ID: 11303321
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
    Lee KB; Kim UK; Lee CC
    J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic kidney disease patients on renal replacement therapy: data from the Catalan Renal Registry.
    Torra R; Darnell A; Cleries M; Botey A; Revert L; Vela E
    Contrib Nephrol; 1995; 115():177-81. PubMed ID: 8585911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.